Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Starpharma releases positive DEP® phase 2 interim results in prostate cancer 2021-11-26 15:41
Premium Red Ginseng Brand CheongKwanJang to Celebrate 122nd anniversary 2021-11-26 15:37
Premium Red Ginseng Brand CheongKwanJang to Celebrate 122nd anniversary 2021-11-26 15:28
Henlius Novel Anti PD-L1/TIGIT Bispecific Antibody Received Clinical Trial Approval in Australia 2021-11-25 17:27
Innovative €250,000 Parenteral Nutrition Research Grant Awarded by Fresenius Kabi 2021-11-25 15:45
Sartorius significantly expands activities in South Korea 2021-11-25 12:42
iX Biopharma Signs Exclusive License Agreement For Wafermine And Other Sublingual Ketamine Wafer Products 2021-11-25 00:18
Mannin GmbH Implements CDD Vault Informatics Platform to Facilitate Data Management and Collaboration 2021-11-24 13:57
IND Application for Phase 3 Registration Study of KN046 in Combination with Chemotherapy for the Treatment of Pancreatic Cancer was Approved by CDE 2021-11-24 09:35
Everest Medicines Announces Inclusion in the MSCI Global Small Cap Indexes - MSCI China Index 2021-11-24 08:00
Seegene Announces Q3 2021 Earnings, Continuing COVID-Era Momentum 2021-11-23 16:03
PromarkerD distribution network expands to Britain 2021-11-23 11:56
EZZ accelerates genomic health focus with launch of two new biotic products 2021-11-23 04:00
Innovent Releases the ORIENT-31 Phase 3 Study First Interim Analysis Results of Sintilimab plus BYVASDA (bevacizumab biosimilar injection) and Chemotherapy in Patients with EGFR-mutated Nonsquamous Non-small Cell Lung Cancer who Progressed After EGFR-TKI Therapy at ESMO Virtual Plenary 2021 2021-11-22 08:16
Innovent Announces Inclusion of the Company's Stock (01801.HK) in the Hang Seng China Enterprises Index 2021-11-22 08:00
CStone Pharmaceuticals and Jiangsu Hengrui Pharmaceuticals announce strategic partnership and exclusive licensing agreement on anti-CTLA-4 monoclonal antibody CS1002 in Greater China 2021-11-21 17:09
Brii Biosciences Joins Hang Seng Composite Index 2021-11-19 19:06
YHLO Revealed Its New Development of CLIA Technology at MEDICA 2021 2021-11-19 14:43
EQT Infrastructure to acquire Icon Group, Australia's largest integrated cancer care provider 2021-11-19 10:21
Investment Confidence in Icon Group to Drive Next Phase of Global Growth With EQT Infrastructure Investment 2021-11-19 09:19
1 98 99 100 101 102 230